Ignite Creation Date:
2024-05-06 @ 3:16 AM
Last Modification Date:
2024-10-26 @ 11:31 AM
Study NCT ID:
NCT02248571
Status:
COMPLETED
Last Update Posted:
2017-11-13
First Post:
2014-08-28
Brief Title:
Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab
Sponsor:
Organization:
iOMEDICO AG